搜尋結果
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 6 日前Eli Lilly & Co.'s shares climbed in early US trading after its experimental drug for ...
FDA Panel Unanimously Recommends Eli Lilly’s Alzheimer’s Drug
Forbes· 6 日前A Food and Drug Administration advisory panel unanimously voted Monday to recommend Eli Lilly’s ...
Why FDA Panel Rejected MDMA Therapy—And What’s Next For Psychedelic Medicine
Forbes· 3 日前High hopes that psychedelic medicines were finally on the pathway to regulation were dashed ...
MLB Execs Project $498 Million Deal Will Keep Juan Soto In New York
Forbes· 5 日前While the average MLB salary reached a record $4.5 million for 2024 amid increasing revenues ...
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 5 日前A Food and Drug Administration expert panel of advisors voted 11-0 yesterday to recommend that ...
China solar panel manufacturers seek government action to halt freefall in prices
Reuters· 4 日前Chinese solar panel manufacturers said they are seeking immediate government intervention to ...
US Senate panel advances bipartisan bill to create new judgeships
Reuters· 3 日前A U.S. Senate panel on Thursday advanced bipartisan legislation that would add 66 new judges to ...
American Solar’s Way Forward
Forbes· 3 日前The increase in productive capacity is not being matched by advances in batteries, grid ...
Pentagon Launched Secret Anti-Vax Campaign To Discredit China During COVID Pandemic, Report Says
Forbes· 2 日前The Department of Defense surreptitiously operated an anti-vaccine campaign aimed at Chinese ...
Eli Lilly’s Alzheimer’s Drug Donanemab Is Being Considered For FDA Approval—Here’s What To Know
Forbes· 6 日前A panel of experts advising the Food and Drug Administration could on Monday recommend Eli ...